Mecwins attends the “8th Sepsis Code Conference” at the Hospital Universitario de la Pricesa in Madrid
On the 12th and 13th of March, Mecwins [...]
Mecwins at CSIC spin-off launch: Driving Innovation
Mecwins is pleased to announce its participation in [...]
Advancing Drug-Induced Liver Injury Detection
Drug-induced liver injury (DILI) remains a major challenge [...]
Mecwins Advances the Determination of pTau217 and pTau181 Biomarker Levels for Alzheimer’s Disease
© Juan Gärtner/stock.adobe.com At Mecwins, we are pushing [...]
Revolutionary AVAC technology for ultra-sensitive and high-throughput biomarker detection unveiled!
At Mecwins, we are excited to share the publication [...]
Mecwins Leads Revolution in Cancer Drug Monitoring
We're excited to announce that Mecwins is playing [...]
Mecwins and Destina Genómica receive CDTI support for an innovative breast cancer early detection project
We are thrilled to share some exciting news: Mecwins, [...]
Exploring the Future of Instrumentation at JCTI – Universidad Autónoma de Madrid
Last Thursday, our CEO Óscar Ahumada and our [...]
Breaking New Ground in Cardiology: Our Experience at “Nano solutions meet big challenges in health”
Last week, Mecwins had the opportunity to participate [...]
Mecwins Concludes Successful Participation at Biotech Showcase 2025
Mecwins is delighted to announce the successful conclusion of [...]
